Dr. Reddy’s Laboratories

No Picture
Business

Personalised medicine is a new thing fast gaining momentum: Deepak Sapra, CEO of Dr Reddy’s Laboratories

May 24, 2024 Mansi Praharaj Comments Off on Personalised medicine is a new thing fast gaining momentum: Deepak Sapra, CEO of Dr Reddy’s Laboratories

Hyderabad, May 24, 2024….The Technology enables drug discovery faster, more efficiently and cheaper, said Mr Deepak Sapra, CEO of Dr. Reddy’s Laboratories while delivering an opening address at DXEM 2024–a day-long Summit on Navigating Digital […]

Dr. Reddy’s Laboratories announces the launch of FXR™ (obeticholic acid) in India
Business

Dr. Reddy’s Laboratories announces the launch of Over-The-Counter Diclofenac Sodium Topical Gel 1%, the store brand version of Voltaren(R) Arthritis Pain in the U.S. Market

September 9, 2020 team Comments Off on Dr. Reddy’s Laboratories announces the launch of Over-The-Counter Diclofenac Sodium Topical Gel 1%, the store brand version of Voltaren(R) Arthritis Pain in the U.S. Market

Hyderabad, India and Princeton, NJ, USA. September 9, 2020 – Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of […]

No Picture
Business

Dr. Reddy’s Laboratories announces the launch of Over-The-Counter Nicotine Polacrilex Lozenges, 2 mg and 4 mg, the store brand version of Nicorette® Lozenges in the U.S. Market

July 15, 2020 team Comments Off on Dr. Reddy’s Laboratories announces the launch of Over-The-Counter Nicotine Polacrilex Lozenges, 2 mg and 4 mg, the store brand version of Nicorette® Lozenges in the U.S. Market

Hyderabad, India and Princeton, NJ, USA. July 14, 2020 – Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DR REDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch […]

Dr. Reddy's Laboratories announces the launch of Desmopressin Acetate Injection USP, 4 mcg/mL in the U.S. Market
Business

Dr. Reddy’s Laboratories announces the launch of an authorized generic version of NitroDur(R) (nitroglycerin) Transdermal Infusion System in the U.S. Market

April 15, 2020 Praveen Comments Off on Dr. Reddy’s Laboratories announces the launch of an authorized generic version of NitroDur(R) (nitroglycerin) Transdermal Infusion System in the U.S. Market

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of authorized generic version of NitroDur® (nitroglycerin) Transdermal Infusion System. The […]

Dr. Reddy's Laboratories announces the launch of Desmopressin Acetate Injection USP, 4 mcg/mL in the U.S. Market
Business

Dr. Reddy’s Laboratories announces the launch of Amphetamine Sulfate Tablets USP, in the U.S. Market

April 15, 2020 Praveen Comments Off on Dr. Reddy’s Laboratories announces the launch of Amphetamine Sulfate Tablets USP, in the U.S. Market

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Amphetamine Sulfate Tablets USP, a therapeutic equivalent generic version of […]